Swiss drug major Roche Group (RHHBY) reported Thursday that its fiscal 2018 IFRS net income rose 23% to 10.87 billion Swiss francs from last year's 8.83 billion francs, reflecting the benefits from the U.S. tax reform and higher net financial income.
from RTT - Earnings http://bit.ly/2WxlNkY
via IFTTT
No comments:
Post a Comment